Expansion plan at Almac prompts recruitment drive
September 29, 2009Manufacturing and Production Almac
Northern Ireland's Almac Group has announced another raft of expansions in its contract research and manufacturing operations, which could boost …
J&J buys stake in vaccines firm Crucell
September 29, 2009Sales and Marketing Crucell, JJ, vaccines
Johnson & Johnson has acquired an 18% stake in Netherlands-based vaccines firm Crucell, and the two companies will work together …
Digital Pharma: From virtual to actual
September 29, 2009Medical Communications digi, digital pharma, hcsmeu
Mental health services have ‘considerable room for improvement’
September 28, 2009NHS, hc
The state of England's mental health services has been lambasted in a report from the Care Quality Commission (CQC). The …
Quality by design pilot extended by FDA
September 28, 2009NHS, hc
The US Food and Drug Administration has extended the deadline for groups wishing to take part in its quality-by-design pilot …
Chop and change for pharma production facilities
September 28, 2009Manufacturing and Production AZ, Teva
Quintiles opens Scottish central lab
September 28, 2009Research and Development Quintiles, Scotland
Quintiles has opened new facilities near Edinburgh, Scotland, that more than double its ability to provide central laboratory services to …
Abbott buys Solvay for $6.6 billion
September 28, 2009Sales and Marketing Abbott, Solvay, cystic fibrosis
Abbott is to buy the pharma division of Belgium-based Solvay for 4.5 billion euros ($6.6 billion) in cash.Solvay declared in …
MBAs: what can they do for your career?
September 25, 2009Business Services MBA, careers, training
A few years ago, getting an MBA was rare enough to seem like an automatic passport to the executive suite. …
Nexavar shows promise in breast cancer
September 24, 2009Sales and Marketing Cancer, Nexavar, breast cancer
Bayer’s Nexavar has been shown to significantly extend progression-free survival in patients with advanced breast cancer in a new phase …
Nycomed earmarks $96m for Russian manufacturing
September 24, 2009Manufacturing and Production Daxas, Nycomed, Russia
Swiss drugmaker Nycomed has provided more details of its plan to build a large-scale production facility in Russia.In July, Nycomed …
GlaxoSmithKline eyes Indian deal
September 23, 2009Sales and Marketing GSK, India
GlaxoSmithKline is said to be looking to buy an Indian firm, according to reports in one of the country's largest …
Janssen-Cilag wins NICE approval for psoriasis drug Stelara
September 23, 2009Sales and Marketing JJ, NICE, Stelara
NICE has approved Janssen-Cilag’s Stelara as a treatment option for adults with moderate to severe plaque psoriasis.Part of the process …
Gerresheimer invests further in plastic packaging
September 23, 2009Manufacturing and Production packaging
Gerresheimer has continued its expansion into the pharmaceutical plastic packaging sector with the construction of two new plants, one in …
GlaxoSmithKline to reform US medical education funding
September 23, 2009Medical Communications CME, US, ethics
GlaxoSmithKline has announced a major shift in its policy for paying for medical education programmes for doctors in the US.The …
Contract research news in brief
September 22, 2009Research and Development CRO
Pharmafocus' periodic round-up of developments in the contract research sector includes an acquisition and alliance for BioClinica, accreditations for ICON …
Pfizer and Icagen extend pain drug deal
September 22, 2009Research and Development Icagen, Pfizer
Pfizer has extended its existing deal with biotech Icagen, aimed at developing new treatments for pain and related disorders. Over …
AZ strikes drug development deal with Nektar Therapeutics
September 22, 2009Research and Development AZ, Nektar
AstraZeneca has licenced two anti-constipation drug development programmes from Nektar Therapeutics in a deal that could be worth more than …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
